BDX
Becton Dickinson and Company
NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$145.31
-2.82% today
Updated 2026-04-29
Market cap
$41.34B
P/E ratio
23.74
P/S ratio
1.89x
EPS (TTM)
$6.12
Dividend yield
2.79%
52W range
$125 – $186
Volume
2.7M
Becton Dickinson and Company (BDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.01%
Operating margin
13.40%
ROE
6.96%
ROA
4.08%
Debt/equity
0.77x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $5.74B | $752.28M | 51.32% | 19.89% | 13.11% |
| 2007 | $6.36B | $890.03M | 51.70% | 18.92% | 13.99% |
| 2008 | $7.07B | $1.13B | 51.28% | 21.72% | 15.93% |
| 2009 | $6.99B | $1.23B | 52.60% | 22.75% | 17.63% |
| 2010 | $7.12B | $1.32B | 51.88% | 22.21% | 18.49% |
| 2011 | $7.58B | $1.27B | 52.20% | 21.97% | 16.76% |
| 2012 | $7.71B | $1.17B | 51.28% | 20.21% | 15.18% |
| 2013 | $8.05B | $1.29B | 51.79% | 15.57% | 16.05% |
| 2014 | $8.45B | $1.19B | 50.92% | 19.01% | 14.03% |
| 2015 | $10.28B | $695.00M | 45.66% | 10.45% | 6.76% |
| 2016 | $12.48B | $976.00M | 47.99% | 11.46% | 7.82% |
| 2017 | $12.09B | $1.10B | 49.33% | 12.59% | 9.10% |
| 2018 | $15.98B | $311.00M | 45.48% | 9.44% | 1.95% |
| 2019 | $17.29B | $1.23B | 47.94% | 10.18% | 7.13% |
| 2020 | $16.07B | $874.00M | 42.29% | 5.67% | 5.44% |
| 2021 | $19.13B | $2.09B | 45.12% | 11.76% | 10.94% |
| 2022 | $18.87B | $1.78B | 44.92% | 12.09% | 9.43% |
| 2023 | $19.37B | $1.48B | 42.17% | 10.90% | 7.66% |
| 2024 | $20.18B | $1.71B | 45.22% | 11.88% | 8.45% |
| 2025 | $21.84B | $1.68B | 45.44% | 11.80% | 7.68% |